Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | HALO | NUVL | ||
| Company | Blueprint Medicines Corp | Halozyme Therapeutic | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 129.35 | 71.63 | 102.53 | ||
| High | 129.55 | 71.99 | 106.21 | ||
| Low | 129.30 | 67.34 | 101.50 | ||
| Latest | 129.46 | 70.03 | 105.22 | ||
| Change | +0.18 | -0.90 | +2.68 | ||
| % Change | +0.14% | -1.27% | +2.61% | ||
| Volume | 2,980,900 | 2,643,700 | 400,900 | ||
| 20-Day Average Volume | 4,470,280 | 1,686,940 | 575,955 | ||
| Previous Close | 129.28 | 70.93 | 102.54 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 66.34 | 104.05 | ||
| 20-Day Raw Stochastic | 88.49% | 66.46% | 63.35% | ||
| 20-Day Relative Strength | 73.17 | 57.82 | 53.19 | ||
| Weighted Alpha | +17.08 | +27.02 | +39.00 | ||
| Today's Opinion | 100% Buy | 24% Buy | 80% Buy | ||
| Previous Opinion | 100% Buy | 16% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 32% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | +5.55% since 05/06/26 | +0.92% since 05/06/26 | ||
| Low | 129.00 on 07/11/25 | 63.50 on 05/11/26 | 100.17 on 05/07/26 | ||
| High | 129.65 on 07/16/25 | 73.89 on 05/12/26 | 109.11 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | +4.55% since 04/13/26 | +1.48% since 04/13/26 | ||
| Low | 128.00 on 06/20/25 | 62.38 on 05/01/26 | 97.77 on 05/01/26 | ||
| High | 129.65 on 07/16/25 | 73.89 on 05/12/26 | 109.53 on 04/22/26 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | -11.85% since 02/13/26 | +4.36% since 02/13/26 | ||
| Low | 83.27 on 04/22/25 | 61.33 on 03/27/26 | 93.91 on 03/24/26 | ||
| High | 129.65 on 07/16/25 | 81.51 on 02/17/26 | 109.53 on 04/22/26 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | -1.63% since 11/13/25 | +11.13% since 11/13/25 | ||
| Low | 73.04 on 04/09/25 | 61.22 on 12/11/25 | 93.05 on 11/14/25 | ||
| High | 129.65 on 07/16/25 | 82.22 on 02/09/26 | 113.01 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,403,360 | 8,061,386 | ||
| Shares Outstanding, K | 64,582 | 118,474 | 78,617 | ||
| Annual Sales | 508,820,000 | 1,396,610,000 | 0 | ||
| Annual Net Income | -67,090,000 | 316,890,000 | -425,380,000 | ||
| Last Quarter Sales | 149,410,000 | 451,770,000 | 0 | ||
| Last Quarter Net Income | 500,000 | -141,590,000 | -109,280,000 | ||
| 60-Month Beta | 0.89 | 0.89 | 1.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | 1.60 on 05/11/26 | -1.39 on 05/07/26 | ||
| Earnings Date | 08/07/25 | 08/04/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.70 | 0.00 | ||